Categories
Top stories

Animal Parasiticides Market Anticipated for Progressive CAGR Growth During 2020-2027

According to a new report published by Research Dive, the global animal parasiticide market forecast will be $7,082.2 million by 2026, rising from $5,096.0 million in 2018, and at 4.2% CAGR.

The significant animal parasiticide market drivers; are increasing the adoption of pet animal’s and awareness about the importance of parasiticide products to prevent zoonotic diseases. Increasing knowledge among the people about livestock and livestock healthcare, rising the concerns to control of zoonotic diseases in the animals and livestock is anticipated to lead the market growth in the future time. Additionally, increasing investments to develop improved parasiticide products for veterinary healthcare and rise in the expenditure on animal healthcare are further enhancing the animal parasiticide market growth in a positive manner. Parasiticide product cost and heavy R&D investments are projected to hamper the global animal parasiticide market. Animal parasiticide market advancements and rise in the government implementations to prevent the animal and livestock health are expected to generate major opportunities for the new entrants into the market in the coming years.

Ectoparasiticide type market will witness a significant growth and is estimated to generate a revenue of $1,678.5 million, at a 4.6% CAGR over projected period. The rise in the demand of ectoparasiticides type to prevent or control parasite insects in animals is anticipated to boost the market growth in the coming years. Endectocides type dominated the global animal parasiticide market, it is registered for $2,293.2 million in 2018, and is projected to account for $3,109.1 million by the end of 2026. This is due to endectocides are major veterinary parasiticide that are used for the treatment of arthropods and nematodes insects affecting animals. Additionally, increase the use of endectocides to minimize parasites diversity is expected to drive the animal parasiticide market in the projected period.

The companion animals segment is expected to experience the substantial growth, it is estimated to register of $2,323.0 million, growing at a highest rate of 4.5% in the projected time frame. This is owing to the growing requirements from pet owners and veterinary centers to prevent or treat animals from the zoonotic diseases. Additionally, rise in the animal healthcare expenditure and number of pet owners are expected to enhance the animal parasiticide market over forecast timeframe. The farm animals segment has registered the highest animal parasiticide market share of 68.0% in 2018, and is estimated to generate revenue of $4,759.3 million, growing at 4.0% CAGR over projected period. This growth is attributed to high quantity requirement of parasiticides, due to huge quantity of farm animals present across the globe.

Asia-Pacific market is projected witness a noteworthy growth rate, it is projected to account for $ 1,614.8 million and at a CAGR of 4.7% in the projected time period, owing to upsurge in the adoption of animals, and increase in the product demand from the quality meat consumers across the region. Additionally, rising awareness about the importance of parasiticides to control the diseases will further drive the market growth in the coming years. North America market is accounted for the highest animal parasiticide market size of $1,885.5 million in 2018, it is estimated to register of $2,556.7 million and at a 3.9% CAGR, owing to rising interest of pet animals owning among the people.

Elanco, Boehringer Ingelheim animal Health, Ceva Santé Animale, Vetoquinol, Eli Lilly, Bayer AG Zoetis Inc., Sanofi, Merck Co., and Perrigo Company Plc, are some of the animal parasiticide market players. These manufacturers are accepting the key approaches such as product infections, collaboration and partnerships in order to rise their market size in the global animal parasiticide market. For example, in September 2019, Zoetis Inc. presented positive effectiveness of triple combination of parasiticide at American Heartworm Society Meeting, which is useful for preventing animals from heartworm disease and to control and treat of fleas, intestinal and ticks in dogs.

Contact Us:

Mr. Abhishek Paliwal
Research Dive
30 Wall St. 8th Floor, New York
NY 10005 (P)
+ 91 (788) 802-9103 (India)
+1 (917) 444-1262 (US) Toll
Free : +1 -888-961-4454
Email: [email protected]
LinkedIn: https://www.linkedin.com/company/research-dive
Twitter: https://twitter.com/ResearchDive
Facebook: https://www.facebook.com/Research-Dive
Blog: https://www.researchdive.com/blog
Follow us on: https://covid-19-market-insights.blogspot.com

Categories
Top stories

What Makes Medical Marijuana Market Outperforming Its Substitutes?

As per study of Research Dive, medical marijuana (cannabis) market forecast revenue of $36,205.4 million in the year 2026 growing at CAGR of 28.7%.

Marijuana is more safe and has less severe side effects over other treatment options such as opioid-based treatments. It is more efficient in reducing nausea and also improving appetite among chemotherapy patients. Increasing cancer burden along with rising demand for chronic pain management & treatment is projected to drive the medical marijuana market growth. For instance, as per publication of the World Health Organization (WHO), in 2018, Cancer disease is the second leading cause of death cases, in which Lung, breast, prostate, liver, stomach and colorectal cancer are the common types of cancerous diseases. Moreover, R&D activities, Clinical trials along with commercialization of cannabis are anticipated to boost the global medical marijuana industry. However, stringent government regulation, lack of awareness in the emerging countries and absence of proper information shall restrain the medical marijuana market growth. China has the significant opportunities for the medical marijuana market; this is majorly due to China is primarily involved in the research and also it has heavy production of marijuana. Moreover, key players such as Hanma Investment Group received permission to extract CBD (Cannabidiol) in China. Currently this company exports 90% of its production, to the countries such as, Germany, the U.K., and the US.

Pain management segment shall generate revenue of $15,133.9 million in 2026, increasing at a CAGR 28.2%. Pain management segment is broadly classified into neuropathic pain, cancer pain, and others. Rising prevalence of cancerous diseases attributed to primarily increase the necessity of pain management across the globe is anticipated to foster the global market.

Inhalation segment shall generate revenue of $25,162.8 million by the end of 2026, at a CAGR of 28.1% till 2026.This segment has enormous opportunities due to properties such as reduction in noxious emissions and quick effects. Topical segment shall generate revenue of $7,965.2 million by the end of 2026, at a CAGR of 30.2% till 2026.

Online segment will see enormous growth owing to, easy accessibility and significant changes in the legality of marijuana attributed to increasing need of E-commerce payment system in cannabis market will generate revenue of $9,558.2 million by the end of 2026, rising at a CAGR 32.3%. Dispensaries segment is expected to generate revenue of $26,647.2 million by the end of 2026, growing at a CAGR of 27.6%.

North America medical marijuana market size will cross $11,404.7 million in 2026, increasing at a CAGR 26.6%. North America marijuana market is anticipated to increase at fast rate owing to legalization of medical marijuana in Canada, in addition, extensive growth in cannabis based products for medicinal use and legalization of cannabis by the House Judiciary Committee in the US is expected boost the market in this regions.

Medical Marijuana market share for Asia-Pacific region is projected to grow at a CAGR of 30.8% by generating a revenue of $8,037.6 by 2026. Asia Pacific region is projected to witness significant growth owing to the piecemeal legalization of medicinal cannabis in the nations such as Australia and Israel. Additionally, Thailand is the nation that has fully legalized medicinal marijuana with multiple clinical applications.

Some of the significant medical marijuana market players are: mCig, Emerald Health Therapeutics, ABcann Medicinals, Inc., Insys Therapeutics, Inc., Aphria, Inc., Cannabis Sativa Inc., Canopy Growth Corporation, GW Pharmaceuticals, Green Relief Inc., and Aurora Cannabis, Inc. These players are initiating various steps in order strengthen their presence such as merger & acquisitions, new product development. For example, to meet the demand of rising number of patients, Green Relief Inc., a licensed manufacturer of marijuana based therapeutic medicines, has officially acquired a new facility department in Canada.

Contact Us:

Mr. Abhishek Paliwal
Research Dive
30 Wall St. 8th Floor, New York
NY 10005 (P)
+ 91 (788) 802-9103 (India)
+1 (917) 444-1262 (US) Toll
Free : +1 -888-961-4454
Email: [email protected]
LinkedIn: https://www.linkedin.com/company/research-dive
Twitter: https://twitter.com/ResearchDive
Facebook: https://www.facebook.com/Research-Dive
Blog: https://www.researchdive.com/blog
Follow us on: https://covid-19-market-insights.blogspot.com

Categories
Top stories

Intrathecal Drug Delivery System Market Expected to Witness Rapid Expansion by the End of 2027

According to a study of Research Dive, intrathecal drug delivery system market forecast shall surpass $1662 Million by 2027, registering a CAGR of 7.2% from 2019 to 2027.

Intrathecal drugs delivery (IDD) system plays the important role in the treatments of intractable (uncontrollable) pain. IDD system utilized for selected patients which are associated with major reduction in quality of health and that have not options of other treatment. This treatment requires highly specialized team for ensuring appropriate selection along with the safety criteria.

IDD enables therapist to formulate individualized treatment regimens which can provide improved analgesia with small doses coupled with fewer adverse effects over opioid-based therapies.

The major factors that boost the global intrathecal drug delivery system market growth are rising demand for intrathecal drug delivery system for cancer pain. In addition, surge in cost-effective cancer pain treatment using such systems are expected to boost the market growth during the forecast period. However, complications of ITDD systems hamper the growth of the intrathecal drug delivery system market.

Externalized and Connected with a pump holds the highest market share amongst the product type segment and is expected to register revenue of $1,358.6 million during the forecast period 2020-2027 at a CAGR of 6.8%. Externalized and connected with a pump is used in situations wherein there’s frequent need of change of catheter such as those who are suffering from cancer. They are in trend as they are cost effective compared to fully implanted systems.

These pumps have proved to be very effective for cancer pain and have been use since the last 3-4 decades and they are still in use as fully implanted systems are still in R&D phase and are not use in major developing countries.

Amongst the Application segment, Spasticity Management for intrathecal drug delivery system market size, generating revenue of $635.1 million in 2018, and is expected to grow at CAGR of 7.1% registering revenue of $1,140.2 million by 2027. ITDD devices are mostly used for spasticity management and with advent of programmable system the spasticity can be managed by controlling the flow of drug delivery. They are majorly used in European countries like Belgium, Germany, UK and others. These systems have opportunities in the developing countries wherein the spasticity problems are more pronounced.

North America has the highest Intrathecal drug delivery system market share globally and is expected to register revenue of $695.9 million growing at a healthy rate of 7.4% over the forecast period. Due to ease usage which signifies better control and long lasting nature of the Intrathecal devices North America market has highest market share for implanted Intrathecal drug device Therefore, it is one of the significant factor for growth of Intrathecal drug devices market.

U.S, hold the majority of the share of the North America market and it is one of the leading countries globally. Companies are spending heavily on research & Development activities, in order to provide innovative and effective pain management solution thereby driving the growth of Intrathecal Drug delivery systems in the country.

Prominent players in Intrathecal Drug Delivery Systems are Medtronic plc is one of the potential manufacturers of programmable intrathecal drug Delivery Systems has successfully launched the Medtronic SynchroMed II (drug infusion pump), which is utilized to deliver drug into a patient’s body. The pump is used together with a catheter to deliver a specific drug to the patient’s spinal fluid. Other major players include Flownix Medical Inc, Teleflex Incorporated, DePay Synthes, Tricumed Medizintechnik GmbH, Smiths Group Plc, Summit Medical Group, B Braun Melsungen AG, Becton, Dickinson & Company and Fresenius Medical Care AG & Co. KGaA.

Contact Us:

Mr. Abhishek Paliwal
Research Dive
30 Wall St. 8th Floor, New York
NY 10005 (P)
+ 91 (788) 802-9103 (India)
+1 (917) 444-1262 (US) Toll
Free : +1 -888-961-4454
Email: [email protected]
LinkedIn: https://www.linkedin.com/company/research-dive
Twitter: https://twitter.com/ResearchDive
Facebook: https://www.facebook.com/Research-Dive
Blog: https://www.researchdive.com/blog
Follow us on: https://covid-19-market-insights.blogspot.com

Categories
Top stories

Why Dynamics of Portable Oxygen Kit Market Is Changing Drastically? What If History Is Any Guide?

According to a new report published by Research Dive, the global portable oxygen kits market was accounted for $1,372.6 million in 2018, is projected to reach $2,616.8 million by 2026, and at 8.4% CAGR.

Growing awareness among the people about prevalence of chronic obstructive pulmonary disease (COPD) and importance of portable oxygen kits while mountain climbing and participating in adventure activities are key drivers for the portable oxygen kit market growth. As per publication of American Academy of Allergy Asthma and Immunology, around 0.255 million people are suffering with respiratory problems in the world, and is anticipated to increase day by day, due to this, the demand for portable oxygen kit is increasing to diagnose the patients. Furthermore, rising demand of portable oxygen kits from aerospace & automotive industry for drivers and pilots to deliver constant oxygen source in the disaster sites and high speed vehicles is expected to drive the market growth over the projected period. Furthermore, rising the usage of portable oxygen kits in the hypoxic zones (where the oxygen levels are very low) is anticipated to increase the demand of portable oxygen kits. Shortage of portable oxygen kits and cost of the oxygen kits are major restraint factors for the market growth.

Based on end use, the home applications segment will witness a noteworthy growth, that is anticipated to account for $1,058.8 million, and increasing with a rate of 8.9% in the projected period. This growth is majorly due to increasing usage of portable oxygen kits in the homes. This portable kits can provide oxygen when the consumer needs addition oxygen supply and regular usage of these kits can minimize the risk of death from low levels of oxygen, due to this, the consumers are utilizing oxygen kits in homes instead of running to the hospitals. Healthcare segment dominated the overall market, and registered a revenue of $590.2 million in 2018, and is estimated to account for $1,125.5 million, at 8.4% CAGR over projected time.

Asia Pacific region market is expected to experience significant growth during the projected time, owing to advancements in healthcare sector. Furthermore, increasing the portable oxygen kits in home application and defense sectors is projected to boost the Asia-Pacific region market growth over projected period. The Asia-Pacific market is anticipated to generate revenue of $782.8 million, and growing with highest CAGR of 9.3% during projected timeframe.

North America region held highest portable oxygen kit market share of 45% in 2018 and is anticipated to continue its dominance over forecast timeframe. The dominance is owing to well established healthcare infrastructure in the region. Moreover, the existence of key manufacturers and increasing the awareness about advanced treatment for COPD related diseases are further anticipated to boost the market growth in North America region, owing to the market is estimated to account for $1,1776.6, at a CAGR of 8.4% in the projected time.

Teijin Limited, O2 Concepts, Chart Industries, Invacare Corporation, Inova Labs Inc., Inogen Inc., Worthington Industries, NIDEK Medical Products Inc., Koninklijke Philips N.V., and DeVilbiss Healthcare, are some of the major portable oxygen kit market players in the world. The manufacturers are implementing key approaches such as joint ventures, product inventions, new product developments, partnerships and collaborations to rise their position in the global market.

Contact Us:

Mr. Abhishek Paliwal
Research Dive
30 Wall St. 8th Floor, New York
NY 10005 (P)
+ 91 (788) 802-9103 (India)
+1 (917) 444-1262 (US) Toll
Free : +1 -888-961-4454
Email: [email protected]
LinkedIn: https://www.linkedin.com/company/research-dive
Twitter: https://twitter.com/ResearchDive
Facebook: https://www.facebook.com/Research-Dive
Blog: https://www.researchdive.com/blog
Follow us on: https://covid-19-market-insights.blogspot.com

Categories
Top stories

Healthcare Gamification Market Outlook: World Approaching Demand & Growth Prospect 2019-2025

The healthcare gamification market share is predicted to grow at a CAGR of 11.9% by generating a revenue of $47,281.5 Million by 2026.

Gamification includes applying the techniques used in game, mechanics of game, and game style in non-gaming applications to engage the audience and make the dull task into more fun and engaging. Basically it is an application of elements in video games, which helps to solve the everyday problem and enables the user to change the behavior, develop skills and enable innovation in health care. The goal of the gamification is to change the behavior of the patient. The increase in the wearables and health & wellness app with gamification is the strong sign that the people are liking it.

The increase in the usage of digitalization and the technology adoption are expected to drive the healthcare gamification market. Many companies are using the digital platform for the people to check their health data. For instance, Pokémon go helped the players to increase the step count of the user, consciously or unconsciously which helps in making them fit without knowing them. By the use of such application, it provides offers and rewards to keep self-motivated and keep a check on their health. So, digitalization and adoption of such technologies is predicted to upsurge the market.

Improper use of these games and training programs is considered to be the biggest restrains for market. These gamifications are programmed in such a way that it can help to attain the objective. But these gamifications are used only for fun purpose and once the desire is being fulfilled then they lose interest on these devices and applications which can hamper the growth of the market in the forecast year.

Casual game is held the largest market share of 42% in the type segment. Causal game is forecasted to grow at a CAGR of 10.2 by generating a revenue of $17,541.5 million by 2026. Casual games are usually build to monitor the user’s behavior and provide necessary therapy.

Prevention accounted for the highest growth rate in the application segment. Rise in the fitness enthusiast with the availability of several app and devices is expected to drive the market for prevention. Prevention application was $4,231.3 million in 2018 and is anticipated to generate a revenue of $11,584.0 million by 2026.

Depending on the end use the market is segmented into consumer based and enterprise based. Enterprise based accounted for the highest growth rate of 15.7% over the forecast period, at $5,577.6 million in 2018. Due to the various benefits offered by the employer the employees are the participation in gamification events has grown considerably in the recent years.

Depending on the region the market is segmented into Asia-Pacific, North America, Europe and LAMEA. Asia Pacific accounted for the highest market share of 32.0% in 2018. Asia pacific is predicted to grow at a CAGR of 11.0% by generating a revenue of $14,184.5 million by 2026. Due to the rise in the population and lesser medical facilities is expected to drive the market for this region.

Key competitors in the market are Mango Health, JawBone, Nike, Hubbub Health, EveryMove, Akili Interactive labs, Bunchball, Microsoft, Ayogo Health, and Fitbit among others. Mango health have developed a new gaming application which rewards patients with points every time they set reminder alerts for the medicine consumption.

Contact Us:

Mr. Abhishek Paliwal
Research Dive
30 Wall St. 8th Floor, New York
NY 10005 (P)
+ 91 (788) 802-9103 (India)
+1 (917) 444-1262 (US) Toll
Free : +1 -888-961-4454
Email: [email protected]
LinkedIn: https://www.linkedin.com/company/research-dive
Twitter: https://twitter.com/ResearchDive
Facebook: https://www.facebook.com/Research-Dive
Blog: https://www.researchdive.com/blog
Follow us on: https://covid-19-market-insights.blogspot.com

Categories
Top stories

Intracranial Pressure Monitoring Devices Market to Deliver Prominent Growth & Striking Opportunities During, 2020-2027

     

According to a recent report published by Research Dive, titled, “Intracranial Pressure Monitoring Devices Market by Procedure, Application and End Use: Global Opportunity Analysis and Industry Forecast, 2019-2026,” the global intracranial pressure monitoring devices market size was valued at US $ 1,256.6 million in 2018, and is projected to reach US $ 1,625.7 million by 2026, registering a CAGR of 3.3% from 2019 to 2026.

North America dominates the market, followed by Europe, Asia-Pacific, and LAMEA. The U.S. dominated the global intracranial pressure monitoring devices market share in 2018, whereas Mexico is expected to grow at a significant rate in the U.S. during the forecast period.

Intracranial pressure monitoring is an important measuring technique to analyse and treat neurological disorders including intracerebral and subarachnoid haemorrhage, hydrocephalus, ischemic stroke, traumatic brain injury (TBI) and meningitis/encephalitis. During the last few decades, the methods of intracranial pressure monitoring have evolved from invasive technique to non-invasive techniques with both advantages and limitations. Any increment in the cranial volume could contribute to the rise in intracranial hypertension. An accurate understanding of intracranial pressure (ICP) monitoring can assist in managing with space-occupying head injuries, lesions, pathological conditions causing an abnormal intracranial pressure, followed by cranial surgeries. The major reason for long term disability and death due to head injuries, haemorrhage and other intracranial pathological situations is a rise in the intracranial pressure. To prevent such conditions, intracranial pressure monitoring has proven to be useful, and indeed life saviour, in the critical care of traumatic brain injuries, hydrocephalus and related cerebral diseases including intracranial haemorrhage, Reye’s syndrome, postoperative sub-occipital brain tumours and cryptococcal meningitis. To prevent such diseases due to raised intracranial pressure, ICP monitoring helps in a great manner. These factors strongly propel the growth prospects of the global intracranial pressure (ICP) monitoring devices market during the forecast period.

The intracranial pressure (ICP) monitoring technique is proposed centuries ago by Kellie and Monroe, even though this method is widely used across the globe due its advantages in terms of accuracy and safety regarding patient’ health. With the advancement in science and technology, numerous invasive and non-invasive techniques to monitor intracranial pressure (ICP) have been developed and some are yet to develop. Intracranial pressure monitoring devices are inexpensive, easy to use, reliable and provide accurate measurement of the pressure inside the head. These factors are likely to propel the demand for intracranial pressure monitoring devices market during the forecast period. With the rising complications associated with the use of invasive ICP monitoring devices, there is continuous research and development on the production of non-invasive intracranial pressure monitoring devices so that risk of infection and haemorrhage can be reduced. The development and use of non-invasive ICP monitoring devices further drive the global intracranial pressure monitoring devices market during the forecast period.

The intracranial pressure monitoring devices play a critical role in measuring inside pressure of the brain. It enables doctors to deal with an uncertain rise and drop in the skull which in turn, reduces the chances of clotting and risk to get even fatal diseases. The medical devices manufacturers are nowadays developing different kind of products which can help scale-up the intracranial pressure monitoring and sensing. For instance, Branchpoint Technologies, a manufacturer of cost-effective solutions offering intracranial pressure monitoring announced that the FDA (Food and Drug Administration) has approved its AURA intracranial monitoring systems. The AURA intracranial pressure monitoring system offers fully wireless and implantable intracranial pressure sensors that enable complete mobile intracranial pressure monitoring in the patients.

Intracranial pressure monitoring devices are of great help in evaluating ICP pressure in the skull’s pressure. However, there are certain risks associated with both invasive and non-invasive intracranial pressure monitoring devices. With the use of an invasive method, there are certain problems such as the risk of infection, short term monitoring and restricted the monitoring of the patient among others. Also, the invasive nature of monitoring devices limits the frequency of evaluation in several neurological situations such as hydrocephalus, therefore hampering the long-term care of patients with compromised intracranial pressure. However, the use of non-invasive monitoring devices overcome the problem associated with the invasive ICP monitoring devices, but the non-invasive ICP monitoring method is not capable of providing accurate results as the invasive one. These factors are expected to hamper the global intracranial pressure (ICP) monitoring devices market during the forecast period.

Key Finding of The Intracranial Pressure Monitoring Devices Market:

– Based on procedure, the invasive segment generated the highest revenue in 2018.
– Based on application, the traumatic brain injury segment was the highest revenue contributor in 2018.

– Based on region, North America contributed the highest market revenue in 2018, followed by Europe, Asia-Pacific, and LAMEA.

The key players analyzed in this report are Continental Medtronic Plc, Integra LifeSciences Corporation, DePuy Synthes, Focus Medical Group Inc., Spiegelberg Gmbh, SOPHYSA, Raumedic AG, HeadSense Medical, Inc., Vittamed, and Linet among others.

Contact Us:

Mr. Abhishek Paliwal
Research Dive
30 Wall St. 8th Floor, New York
NY 10005 (P)
+ 91 (788) 802-9103 (India)
Free : +1 -888-961-4454
Email: [email protected]
LinkedIn: https://www.linkedin.com/company/research-dive
Twitter: https://twitter.com/ResearchDive
Facebook: https://www.facebook.com/Research-Dive
Blog: https://www.researchdive.com/blog
Follow us on: https://covid-19-market-insights.blogspot.com

Categories
Top stories

Ultrasonic Displacement Sensor Market Set to Garner Staggering Revenues and Demand by 2020-2027

     

According to a recent report published by Research Dive, titled, “Ultrasonic Displacement Sensor Market by Type, Component, Transducer Type, and End-users: Global Opportunity Analysis and Industry Forecast, 2019-2025,” the global Ultrasonic Displacement Sensor market size was valued at $ 2,627.65 Million in 2018, and is projected to reach $ 4,736.67 Million by 2025, registering a CAGR of 8.86% from 2019 to 2025.

North America dominates the market, followed by Europe, Asia-Pacific, and LAMEA. U.S. dominated the global Ultrasonic Displacement Sensor market share in 2018, whereas Canada is expected to grow at a significant rate in the U.S. during the forecast period. Ultrasonic displacement sensors are basically used to detect objects and measure distance in industrial applications in which versatility and reliability are the key factors. For instance, Pepperl+Fuchs offers a wide variety of ultrasonic sensors which feature benefits such as large measuring ranges of up to 10 m, adjustable sound beams, and minimal dead bands, among others in wide range of housing designs. This automatically helps to offer reliable and efficient solutions.

Furthermore, the ultrasonic displacement sensors offer impressive functionality, measurements by transmitting high-frequency sound pulses which are completely inaudible to humans. The sensors operate according to a time-of-flight measurement, by which they measure the time between transmitting the sound waves and receiving the object reflection. The devices help objects to be detected and their distance from the sensor to be measured. Pepperl+Fuchs ultrasonic sensors are equipped with integrated temperature compensation for reliable and accurate measurement. Hence, these ultrasonic displacement sensors are used drastically in industrial applications.

Furthermore, the smart healthcare systems use ultrasonic sensor and IR proximity sensors in the hospitals and in other healthcare systems. Both these sensors are used for two different purposes and also to perform different functions as well. The healthcare system uses Arduino Uno for the connection of the sensors and the overall implementation of the system. The data gathered by the two sensors is sent to the server immediately. Therefore, the increasing development in the technologies related to Internet of things (IoT) is helping to make possible by connecting and communicating of various smart devices together using the Internet and these sensors.

Ultrasonic displacement sensors are used drastically for gathering information regarding the patient. With the changing society and lifestyle, humans are facing other problems such as increased lifestyle-related diseases and accelerating aging. For instance, a movement for reliable health care is gaining ground in society, trying to determine the variations in your body occurring in your daily life and preventing diseases on a routine basis. The ultrasonic sensors can be used to change an individual’s’ physical condition by applying the sensor to the body and turning the obtained biological information into visual images. The growing demand of such sensors are expected to boost the growth of the ultrasonic displacement sensors market. North American region is the market leader in the ultrasonic displacement sensors market due to various reasons.

The market penetration is quite high in this region due to presence of several healthcare giants is a very crucial growth factor. Among the countries of North America, the United States holds most of the market share, while the Canadian market is estimated to grow faster than the US market. Also, the health expenditure per capita in the U.S. is higher compared to other countries. The rising demand for better surgical procedures by health-conscious citizens is driving the market for ultrasonic displacement sensors in this region.

Factors such as Increasing demand from the industrial sector is driving the growth of ultrasonic displacement sensors market. In addition, the growing need for ultrasonic displacement sensors in the healthcare segment is anticipated boost the growth of the market over the forecast period. However, dominance of other form of sensors in the market and operational issues are expected to hinder the growth of the Ultrasonic displacement sensors.

The key players analyzed in the Ultrasonic Displacement Sensor market include ABB, Siemens AG, Pepperl+Fuchs, Honeywell International Inc., Baumer Ltd, Rockwell Automation, Murata Manufacturing Co. Ltd, Omron Corporation, Sick AG, Banner Engineering and others.

Contact Us:

Mr. Abhishek Paliwal
Research Dive
30 Wall St. 8th Floor, New York
NY 10005 (P)
+ 91 (788) 802-9103 (India)
Free : +1 -888-961-4454
Email: [email protected]
LinkedIn: https://www.linkedin.com/company/research-dive
Twitter: https://twitter.com/ResearchDive
Facebook: https://www.facebook.com/Research-Dive
Blog: https://www.researchdive.com/blog
Follow us on: https://covid-19-market-insights.blogspot.com

Categories
Top stories

Tubeless Insulin Pump Market to Reflect Impressive Growth Rate During 2020 to 2027

     

A new research report, Tubeless Insulin Pump Market, published by Research Dive forecast the global market growth is projected to a CAGR of 23.4% generating a revenue of $ 2,837.6 million by 2026.

As per the World Health Organization (WHO), in 2016 the death occurred due to the diabetes was approx. 1.6 million. At present the diabetes is not only found in the elderly people but it also affects all the age groups. Increasing diabetes cases across the globe is one of the major factor which are driving the tubeless insulin pump market. The infections and the injuries done by the traditional invasive insulin are the factors which increases the demand for the tubeless insulin pump market. It has been predicted that the technology development in the tubeless insulin pump market would increase and diminish the demand for the traditional invasive insulin.

The initiative taken by the government across the globe to aware the general public about the Medicare policies and how to manage the diabetes issues would make a huge impact in the increase in the size of the tubeless insulin pump market.

The price of the tubeless insulin pump is considered to be the biggest restrains in the tubeless insulin pump market. In case of failure in the pump there is a high risk of diabetic ketoacidosis. The pump usually fails when it cannot produce enough insulin. Diabetic ketoacidosis is a severe diabetic problem that generates when your body produces high blood acid levels.

A pod is projected to drive the market of tubeless insulin pump market in the forecast period. A pod is a latest tubeless insulin pump with advanced techniques.

Growing Segments of Tubeless Insulin Pump Market:

The tubeless insulin pump market shares for the e-commerce channel stood at $279.7 million in 2018 and is expected to surpass $1,513.7 million by 2026, at 23.5% CAGR in the forecast period. As the Ecommerce channel is the most widely used platform which provides a varieties of insulin product to the consumer. Pharmacies channel is projected to observe growth of over 25.4% CAGR till the end of 2026 followed by ecommerce channel.

Regional Growth of Tubeless Insulin Pump Market:

Based on the region, North America stood at over $184.7 million in 2018 and is projected to grow at a CAGR of 22.3% in the forecast period. The region is estimated to grow due to the increasing number of the elderly populace and lack of exercise. As these regions have an increasing number of diabetic population which create more opportunity for insulin product manufacturer which will increase their revenue and make an effect on the tubeless insulin pump market.

Asia-Pacific Tubeless Insulin Pump market Forecast:

Asia-Pacific stood at $121.4 million by 2018 end, and is expected to surpass $747.0 million by 2026, at a CAGR of 25.5% due to the increase in number of patient and government spending on awareness program for the control of diabetes within the patient will contribute to the tubeless insulin pump market growth.

Market Dominance Players:

The tubeless insulin pump market players are Spring Health Solution Ltd, Insulet Corporation, Meldrum Technologies Inc., Rosh Holding AG, Johnson & Johnson, Medtrum Technologies Inc, CeQur SA, Debiotech, Cellnovo Group SA, Abbott Diabetes Care and among others. The competitive landscape analysis of tubeless insulin pump market is analyzed as per the above players.

Recent Developments in Tubeless Insulin Pump Market:

Strategic collaborations between major industry giants have led to new innovations across the tubeless insulin pump market. In 2016, a U.S. based pharmaceutical firm, Insulet Corporation and another company named, Eli Lilly & Company signed an agreement for creating a new tubeless Omni pod insulin delivery system for distributing highly concentrated U500 and U200 formulations of insulin. Thus, it is an undeniable fact that collaborations between the key players will have an important influence on the global business.

Contact Us:

Mr. Abhishek Paliwal
Research Dive
30 Wall St. 8th Floor, New York
NY 10005 (P)
+ 91 (788) 802-9103 (India)
Free : +1 -888-961-4454
Email: [email protected]
LinkedIn: https://www.linkedin.com/company/research-dive
Twitter: https://twitter.com/ResearchDive
Facebook: https://www.facebook.com/Research-Dive
Blog: https://www.researchdive.com/blog
Follow us on: https://covid-19-market-insights.blogspot.com

Categories
Top stories

Oxygen Cylinder and Concentrator Market: Current Trends and Future Estimations to Elucidate Imminent Investment Pockets

     

According to a study, Oxygen Cylinder and Concentrator Market by Research Dive, the market is expected to reach $5,052.1 million by 2026, registering a CAGR of 8.7% from 2019-2026.

Growing utilization from different applications and increasing focus on consumption are some of the oxygen cylinder and concentrator market drivers.

The oxygen cylinder and concentrator market is primarily dominated by growing utilization from different applications, for instance, healthcare, pharmaceutical & biotechnology and manufacturing industries. According to American Academy of Allergy, Asthma & Immunology (AAAAI), about 320 million people worldwide are diagnosed with Asthma, of which about 255000 are suffering from the disease. However, it is estimated that by the end of 2026, the number of asthma patients would continue to grow by more than 102 million. This factors further enhance the market in healthcare and medical segment. Additionally, rising demands for adventure sports such as mountain climbing and scuba diving is additional factor for the market growth. Moreover, increasing air pollution, rising the oxygen cylinder usage in manufacturing and production industry will drive the growth of the market in the coming years. The oxygen cylinder and concentrator market size is restrained by the oxygen cylinder production rate, availability of oxygen cylinders and price of the concentrators.

The global oxygen cylinder and concentrator market is segmented into fixed and portable concentrator. The market is dominated by portable oxygen concentrators, and it is predicted to reach $2875.5 million by 2026 and at a growth rate of 8.4%, it is expected continue to dominate in the coming years, due to their mobility and easy handling. Fixed concentrator market is expected to grow at a CAGR of 9.1%, and projected to reach $2176.6 million by the end of 2026.

Based on end-use, the global oxygen cylinder and concentrator market is dominated by healthcare industry and growing at 8.4% CAGR. The market for healthcare sector is accounted for $1231.3 million in 2018, it is expected to reach $2347.5 million during forecast timeframe, this is mainly owing to the rising demand from oxygen dependent patients. Over the forecast period, the manufacturing industry is projected to reach $1152.8 million by the end of 2026, and expected to increase the market, growing at a CAGR of 9.8%. Along with manufacturing industry, pharmaceutical & biotechnology industry is witness to upsurge growth of the market over forecast period, at a CAGR of 8.9%.

Asia Pacific oxygen cylinder and concentrator market Forecast:

The oxygen cylinder and concentrator market for Asia Pacific has generated $724.2 million in 2018, at a CAGR of 9.3% and is projected to reach 1475.2 million by the end of 2026. India market is anticipated to experience vigorous growth in the coming years, due to the growing demands form pharmaceutical & biotechnology and manufacture sectors in Asia Pacific.

North America Oxygen Cylinder and concentrator market Growth:

North America region accounted to hold the majority of the market share and dominated the market in 2018, generating a revenue of 2200.8 million by 2026, at a CAGR of 8.4%. In 2018, U.S. produced 42% of regional oxygen cylinder and concentrator market share, due to the frequently occurrence of respiratory problems caused because of the sudden change in climatic conditions along increasing number of aged populace will drive the growth of the market.

Chart Industries (AirSep), Inogen Inc., NIDEK Medical Products Inc., DeVilbiss Healthcare (Drive DeVilbiss Healthcare), Invacare Corporation, Worthington Industries, Inova Labs Inc (ResMed), Koninklijke Philips N.V. (Philips Healthcare), Teijin Limited Company and O2 Concepts are some of the global oxygen cylinder and concentrator market players.

These companies are adopting new technologies and R&D advancements to gain major share in overall market. Current improvements in market by Teijin Limited Company includes in new device launch “Therapeutic oxygen concentrator: Hi-Sanso”, in order to increase their share in overall oxygen cylinder and concentrator market.

Contact Us:

Mr. Abhishek Paliwal
Research Dive
30 Wall St. 8th Floor, New York
NY 10005 (P)
+ 91 (788) 802-9103 (India)
Free : +1 -888-961-4454
Email: [email protected]
LinkedIn: https://www.linkedin.com/company/research-dive
Twitter: https://twitter.com/ResearchDive
Facebook: https://www.facebook.com/Research-Dive
Blog: https://www.researchdive.com/blog
Follow us on: https://covid-19-market-insights.blogspot.com

Categories
Top stories

Organ Care System for Liver Market Likely to Emerge Over a Period of 2020 – 2027

     

According to a study, Organ Care System Market Share for Liver by Research Dive, will surpass $40.5 million by the end of 2026. Rising prevalence of liver disease patients, coupled with the decreased surgical complications in liver transplantation will upsurge the global market by the year 2026.

The organ care system (OCS) is medical device which maintain organ viability by providing an artificially regulated environment that stimulates near-normal physiological conditions. This cutting-edge technology allows institutions and physicians to maximize the potential of donor liver along with monitoring of liver throughout the entire process, assuring transplant teams can preserve organs in an optimal condition. growing burden of liver cirrhosis worldwide, reducing post-transplantation complications and shortening the length of hospital stay are expected to drive the market organ care system for liver. Moreover, livers have longer acceptable ischemic time, if compared with liver & heart. However, alcohol relapse after liver transplantation(LT) and high degree of risk such factors can restrain the growth of OCS market for liver. In addition, ethical issues are also lag behind the technical advances. According to Brazilian Transplants Registry – ABTO, globally, Brazil occupies in the top five positions for liver transplantation. Furthermore, key factors such as significant growth in the number of transplantation centers, consequent growth in the number of liver transplants & expansion of living donor programs are expected to grow the Organ Care System Market share for Liver.

On the basis of mode of handling, organ care system market for liver is bifurcated into Trolley based organ care system and portable based organ care system.

Trolley based organ care system for liver generated revenue of $12.0 million in 2018, and it is expected to reach upto $22.4 million by the 2026.

Portable OCS market for liver reached upto $9.1 million in 2018, and it is projected to reach upto $18.1 million by the end 2026.ease-of-handle and requirement of less space coupled with due to newest technological invention of cold storage in the portable organ care system expected to upsurge the organ care system market growth.

North America’s OCS Market size for Liver was $8.9 million by end of 2018 and is anticipated to rise at 10.0% CAGR during the analyzed period. Asia-Pacific organ care system market for liver market registered a growth rate of 7.2% during the forecast period. This market will surpass $6.0 million by 2026, growing from $3.5 million in 2018. China, India, and Taiwan are the key contributors to the growth of regional market.

Some of the significant key players in the global organ care system market for liver are TransMedics Inc., Bridge to Life Ltd., Organ Assist B.V., Organ Recovery Systems Inc., Water Medical System LLC, Preservation Solution Inc., XVIVO Perfusion AB, Paragonix Technologies Inc., Preservation Solution Inc., Organ Transport System Inc., OrganOx Limited, such players are beginning with various strategies to strengthen their presence such as new product development, merger & acquisitions etc. For instance, MyCartis & XVIVO collaborated to develop a fast diagnostic test to check the quality of organs which are donated.

Contact Us:

Mr. Abhishek Paliwal
Research Dive
30 Wall St. 8th Floor, New York
NY 10005 (P)
+ 91 (788) 802-9103 (India)
Free : +1 -888-961-4454
Email: [email protected]
LinkedIn: https://www.linkedin.com/company/research-dive
Twitter: https://twitter.com/ResearchDive
Facebook: https://www.facebook.com/Research-Dive
Blog: https://www.researchdive.com/blog
Follow us on: https://covid-19-market-insights.blogspot.com